West Pharmaceutical Services, Inc.

Equities

WST

US9553061055

Market Closed - Nyse Other stock markets 02:30:03 11/02/2026 am IST			5-day change	1st Jan Change
243.56 ^USD	-2.16%		+5.46%	-11.48%

10/02	Jefferies Adjusts Price Target on West Pharmaceutical Services to $295 From $365, Maintains Buy Rating	MT
05/02	West Pharmaceutical Services, Inc. - Special Call

Transcript : West Pharmaceutical Services, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 09

Published on 01/15/2026 at 12:05 am IST - Modified on 01/15/2026 at 02:35 am IST

S&P Capital IQ

Presenter Speech
Unknown Analyst (Analysts)

Good morning, all, and welcome. My name is [ Fazi Kash], and I'll be moderating today's session. It is my pleasure to introduce Eric Green, President, CEO

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about West Pharmaceutical Services, Inc.

10/02	Jefferies Adjusts Price Target on West Pharmaceutical Services to $295 From $365, Maintains Buy Rating	MT
05/02	West Pharmaceutical Services, Inc. - Special Call
03/02	Evercore ISI Adjusts Price Target on West Pharmaceutical Services to $320 From $390	MT
16/01	Ondas Seeks Acquisitions	CI
15/01	West Pharmaceutical Services, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 09:00 AM
12/01	West Pharmaceutical Services, Inc. Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose 3.5mL On-Body Delivery System to AbbVie	CI
12/01	AbbVie Inc. (NYSE : ABBV) entered into a definitive agreement to acquire Device manufacturing facility in Tempe, Arizona from West Pharmaceutical Services, Inc. (NYSE : WST).	CI
12/01	AbbVie to Buy Arizona Device Manufacturing Facility From West Pharmaceutical	MT
12/01	AbbVie to Acquire Drug Delivery System, Arizona Manufacturing Facility from West Pharma	DJ
09/01	Illumina Appoints Chief Medical Officer	MT
19/12	Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $340 From $345, Maintains Buy Rating	MT
10/12	West Pharmaceutical Services, Inc. Declares Regular Quarterly Dividend on Common Stock, Payable on February 4, 2026	CI
10/12	West Pharmaceutical Services Keeps Quarterly Dividend at $0.22 a Share, Payable Feb. 4 to Shareholders of Record on Jan. 28	MT
03/12	West Pharmaceutical Services, Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-02-2025 02:30 PM
02/12	Morgan Stanley Initiates West Pharmaceutical Services at Equalweight With $285 Price Target	MT
20/11	West Pharmaceutical Services, Inc. Presents at Stephens Annual Investment Conference 2025, Nov-20-2025 11:00 AM
18/11	West Pharmaceutical Services, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 10:00 AM
11/11	West Pharmaceutical Services, Inc. Presents at UBS Global Healthcare Conference 2025, Nov-11-2025 09:30 AM
07/11	West Pharmaceutical launches solution for injectable biologics
31/25/31	Rothschild & Co Redburn Adjusts Price Target on West Pharmaceutical Services to $325 From $311	MT
30/25/30	Cartesian Therapeutics, Inc. Announces Board and Committee Changes, Effective from October 29, 2025	CI
29/25/29	TD Cowen Initiates West Pharmaceutical Services at Buy With $350 Price Target	MT
27/25/27	Stephens Adjusts Price Target on West Pharmaceutical Services to $350 From $335	MT
27/25/27	Jefferies Adjusts Price Target on West Pharmaceutical Services to $365 From $335, Maintains Buy Rating	MT
27/25/27	West Pharmaceutical Services, Inc. Announces the Launch of its West Synchrony Prefillable Syringe System at CPHI Worldwide in Frankfurt, Germany	CI